Most Clinicians Support Use of Medicinal Marijuana

Share this content:
Majority of Clinicians Support Medicinal Marijuana Use
Majority of Clinicians Support Medicinal Marijuana Use

(HealthDay News) -- A majority of clinicians appears to support the use of medicinal marijuana, according to research published in the May 30 issue of the New England Journal of Medicine.

Jonathan N. Adler, M.D., and James A. Colbert, M.D., associate editors for the New England Journal of Medicine, describe the results of polling and comments in an interactive feature in which experts discussed the use of medicinal marijuana for a 68-year old woman with metastatic breast cancer.

The authors report that, although marijuana is illegal in most countries, 76% of all 1,446 votes, cast in 72 countries, were in favor of marijuana use for medicinal purposes. Within North America, 76% of voters supported medicinal marijuana use. More than 50% of voters supported marijuana use in each state and province with at least 10 voters, with the exception of Utah, where only 1% of 76 voters supported marijuana use. In Pennsylvania, 96% of 107 votes supported the use of medicinal marijuana. The results in Latin America and Europe were similar, with 78% of voters supporting marijuana use. Individual perspectives expressed within the 118 comments were polarized.

"In sum, the majority of clinicians would recommend the use of medicinal marijuana in certain circumstances," the authors write. "Large numbers of voices from all camps called for more research to move the discussion toward a stronger basis of evidence."

Full Text

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs